Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.36
LNDC's Cash to Debt is ranked lower than
61% of the 989 Companies
in the Global Chemicals industry.

( Industry Median: 0.68 vs. LNDC: 0.36 )
LNDC' s 10-Year Cash to Debt Range
Min: 0.07   Max: No Debt
Current: 0.36

Equity to Asset 0.65
LNDC's Equity to Asset is ranked higher than
70% of the 989 Companies
in the Global Chemicals industry.

( Industry Median: 0.56 vs. LNDC: 0.65 )
LNDC' s 10-Year Equity to Asset Range
Min: 0.37   Max: 0.96
Current: 0.65

0.37
0.96
Interest Coverage 12.38
LNDC's Interest Coverage is ranked higher than
59% of the 655 Companies
in the Global Chemicals industry.

( Industry Median: 16.51 vs. LNDC: 12.38 )
LNDC' s 10-Year Interest Coverage Range
Min: 0.81   Max: 1574.75
Current: 12.38

0.81
1574.75
F-Score: 5
Z-Score: 4.07
M-Score: -2.32
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.63
LNDC's Operating margin (%) is ranked higher than
68% of the 969 Companies
in the Global Chemicals industry.

( Industry Median: 5.76 vs. LNDC: 5.63 )
LNDC' s 10-Year Operating margin (%) Range
Min: -204.76   Max: 14.43
Current: 5.63

-204.76
14.43
Net-margin (%) 5.11
LNDC's Net-margin (%) is ranked higher than
74% of the 969 Companies
in the Global Chemicals industry.

( Industry Median: 3.76 vs. LNDC: 5.11 )
LNDC' s 10-Year Net-margin (%) Range
Min: -204.76   Max: 13.87
Current: 5.11

-204.76
13.87
ROE (%) 12.64
LNDC's ROE (%) is ranked higher than
88% of the 961 Companies
in the Global Chemicals industry.

( Industry Median: 6.54 vs. LNDC: 12.64 )
LNDC' s 10-Year ROE (%) Range
Min: -37.7   Max: 26.48
Current: 12.64

-37.7
26.48
ROA (%) 7.76
LNDC's ROA (%) is ranked higher than
89% of the 974 Companies
in the Global Chemicals industry.

( Industry Median: 3.39 vs. LNDC: 7.76 )
LNDC' s 10-Year ROA (%) Range
Min: -17.13   Max: 20.65
Current: 7.76

-17.13
20.65
ROC (Joel Greenblatt) (%) 26.07
LNDC's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 970 Companies
in the Global Chemicals industry.

( Industry Median: 10.99 vs. LNDC: 26.07 )
LNDC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -58.82   Max: 123.51
Current: 26.07

-58.82
123.51
Revenue Growth (%) 22.90
LNDC's Revenue Growth (%) is ranked higher than
92% of the 788 Companies
in the Global Chemicals industry.

( Industry Median: 5.10 vs. LNDC: 22.90 )
LNDC' s 10-Year Revenue Growth (%) Range
Min: -13.2   Max: 144.9
Current: 22.9

-13.2
144.9
EBITDA Growth (%) 50.20
LNDC's EBITDA Growth (%) is ranked higher than
98% of the 685 Companies
in the Global Chemicals industry.

( Industry Median: 4.00 vs. LNDC: 50.20 )
LNDC' s 10-Year EBITDA Growth (%) Range
Min: -43.2   Max: 58.7
Current: 50.2

-43.2
58.7
EPS Growth (%) 78.30
LNDC's EPS Growth (%) is ranked higher than
97% of the 635 Companies
in the Global Chemicals industry.

( Industry Median: 3.20 vs. LNDC: 78.30 )
LNDC' s 10-Year EPS Growth (%) Range
Min: -66.2   Max: 113.5
Current: 78.3

-66.2
113.5
» LNDC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

LNDC Guru Trades in Q1 2013

John Rogers 495,654 sh (+59.13%)
Chuck Royce 75,610 sh (unchged)
Jim Simons 262,000 sh (-17.4%)
» More
Q2 2013

LNDC Guru Trades in Q2 2013

John Rogers 598,499 sh (+20.75%)
Chuck Royce 75,610 sh (unchged)
Jim Simons 223,600 sh (-14.66%)
» More
Q3 2013

LNDC Guru Trades in Q3 2013

Paul Tudor Jones 52,500 sh (New)
John Rogers 979,575 sh (+63.67%)
Jim Simons 358,751 sh (+60.44%)
Chuck Royce 75,610 sh (unchged)
» More
Q4 2013

LNDC Guru Trades in Q4 2013

John Rogers 2,057,722 sh (+110.06%)
Chuck Royce 75,610 sh (unchged)
Paul Tudor Jones Sold Out
Jim Simons 245,200 sh (-31.65%)
» More
» Details

Insider Trades

Latest Guru Trades with LNDC



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 17.00
LNDC's P/E(ttm) is ranked higher than
65% of the 808 Companies
in the Global Chemicals industry.

( Industry Median: 18.40 vs. LNDC: 17.00 )
LNDC' s 10-Year P/E(ttm) Range
Min: 7   Max: 127.83
Current: 17

7
127.83
P/B 1.65
LNDC's P/B is ranked higher than
60% of the 960 Companies
in the Global Chemicals industry.

( Industry Median: 1.59 vs. LNDC: 1.65 )
LNDC' s 10-Year P/B Range
Min: 0.94   Max: 4.29
Current: 1.65

0.94
4.29
P/S 0.71
LNDC's P/S is ranked higher than
66% of the 1003 Companies
in the Global Chemicals industry.

( Industry Median: 0.96 vs. LNDC: 0.71 )
LNDC' s 10-Year P/S Range
Min: 0.38   Max: 1.88
Current: 0.71

0.38
1.88
PFCF 45.04
LNDC's PFCF is ranked lower than
53% of the 493 Companies
in the Global Chemicals industry.

( Industry Median: 19.52 vs. LNDC: 45.04 )
LNDC' s 10-Year PFCF Range
Min: 10.15   Max: 255.67
Current: 45.04

10.15
255.67
EV-to-EBIT 18.33
LNDC's EV-to-EBIT is ranked lower than
54% of the 844 Companies
in the Global Chemicals industry.

( Industry Median: 14.90 vs. LNDC: 18.33 )
LNDC' s 10-Year EV-to-EBIT Range
Min: 4.5   Max: 106.6
Current: 18.33

4.5
106.6
PEG 0.57
LNDC's PEG is ranked higher than
86% of the 501 Companies
in the Global Chemicals industry.

( Industry Median: 1.60 vs. LNDC: 0.57 )
LNDC' s 10-Year PEG Range
Min: 0.15   Max: 9.5
Current: 0.57

0.15
9.5
Shiller P/E 26.43
LNDC's Shiller P/E is ranked higher than
55% of the 441 Companies
in the Global Chemicals industry.

( Industry Median: 22.21 vs. LNDC: 26.43 )
LNDC' s 10-Year Shiller P/E Range
Min: 9.47   Max: 239.67
Current: 26.43

9.47
239.67

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.58
LNDC's Price/Tangible Book is ranked lower than
66% of the 908 Companies
in the Global Chemicals industry.

( Industry Median: 1.70 vs. LNDC: 3.58 )
LNDC' s 10-Year Price/Tangible Book Range
Min: 1.1   Max: 124.33
Current: 3.58

1.1
124.33
Price/DCF (Projected) 1.77
LNDC's Price/DCF (Projected) is ranked higher than
56% of the 426 Companies
in the Global Chemicals industry.

( Industry Median: 1.40 vs. LNDC: 1.77 )
LNDC' s 10-Year Price/DCF (Projected) Range
Min: 0.89   Max: 44.56
Current: 1.77

0.89
44.56
Price/Median PS Value 0.93
LNDC's Price/Median PS Value is ranked higher than
80% of the 915 Companies
in the Global Chemicals industry.

( Industry Median: 1.10 vs. LNDC: 0.93 )
LNDC' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 47.66
Current: 0.93

0.3
47.66
Price/Peter Lynch Fair Value 0.68
LNDC's Price/Peter Lynch Fair Value is ranked higher than
82% of the 241 Companies
in the Global Chemicals industry.

( Industry Median: 1.19 vs. LNDC: 0.68 )
LNDC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.41   Max: 26
Current: 0.68

0.41
26
Price/Graham Number 1.64
LNDC's Price/Graham Number is ranked lower than
51% of the 761 Companies
in the Global Chemicals industry.

( Industry Median: 1.30 vs. LNDC: 1.64 )
LNDC' s 10-Year Price/Graham Number Range
Min: 0.92   Max: 10.48
Current: 1.64

0.92
10.48
Earnings Yield (Greenblatt) 5.50
LNDC's Earnings Yield (Greenblatt) is ranked higher than
51% of the 886 Companies
in the Global Chemicals industry.

( Industry Median: 6.60 vs. LNDC: 5.50 )
LNDC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.9   Max: 22.1
Current: 5.5

0.9
22.1
Forward Rate of Return (Yacktman) 30.14
LNDC's Forward Rate of Return (Yacktman) is ranked higher than
95% of the 596 Companies
in the Global Chemicals industry.

( Industry Median: 6.16 vs. LNDC: 30.14 )
LNDC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -22.1   Max: 47.4
Current: 30.14

-22.1
47.4

Business Description

Industry: Chemicals » Chemicals
Compare:BASFY, DD, SHECY, URALL, APD » details
Traded in other countries:LDE.Germany
Landec Corporation is incorporated in California on October 31, 1986 and reincorporated as a Delaware corporation on November 6, 2008. The company and its subsidiaries design, develop, manufacture and sell polymer products for food and agricultural products, medical devices and licensed partner applications that incorporate Landec's patented polymer technologies. The Company has two proprietary polymer technology platforms: 1) Intelimer polymers, and 2) hyaluronan ('HA') biopolymers. The Intelimer polymer is a crystalline and hydrophobic polymer. The first feature of this polymer system is the way that it uses a temperature switch to control and modulate properties such as viscosity, permeability and adhesion when varying the materials' temperature above and below the temperature switch. A second unique feature of the Intelimer polymer materials is its unique controlled release properties. The polymer is able to deliver active ingredients with low or no burst, with a sustained release over periods of time. Finally, Intelimer polymers can be designed to contain up to 80% renewable materials from components of natural raw materials such as rapeseed oil, palm oil or coconut oil, and can be supplied in biocompatible and bioerodible forms. Its Hyaluronan Biopolymers is a non-crystalline, hydrophilic polymer that exists naturally within the human body, notably within the aqueous humor of the eye, synovial fluid, skin and umbilical cord. The viscoelastic properties and water solubility of HA make it ideal for medicinal applications where lubricity and protection are critical. Due to its widespread presence in tissues, its critical role in normal physiology and its high degree of biocompatibility, the Company believes that hyaluronan will continue to be used for an increasing variety of medical applications. Some of the Company's products are subject to extensive and rigorous regulation by the FDA, which regulates some of the products as medical devices and which, in some cases, requires Pre-Market Approval ('PMA'), and by foreign countries, which regulate some of the products as medical devices or drugs.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide